
UC San Diego researchers used teleoperated humanoid robots to perform gallbladder removal and other procedures, demonstrating a path to remote specialist surgery for underserved areas.
Researchers at the University of California San Diego have finished the first surgical procedures ever performed by teleoperated humanoid robots. The preclinical trial used robots nicknamed Surgie to complete two operations on large non-primate mammals.
One setup paired a humanoid robot with a human surgeon for a gallbladder removal. The second used two humanoid robots working together on a separate surgery. In both cases the robots were controlled remotely by a surgeon using specialized controllers that mirror hand movements in real time. The surgeon can be hundreds or even thousands of kilometers away.
The trial is a proof of concept, researchers said. It shows humanoid robots can safely perform complex surgical tasks under human supervision. Unlike autonomous surgical systems, these machines have no independent decision-making capability. Every move is directed by a human operator.
Surgie stands about 5 feet tall and weighs roughly 60 pounds. That is a fraction of the size of current robotic surgery systems, which can weigh around 1,800 pounds. The humanoid design allows the robot to use conventional surgical instruments with little modification. Existing operating rooms need no major infrastructure changes to accommodate it.
The humanoid form also means the robot can handle tasks beyond surgery. Researchers said the same platform could assist with equipment movement, patient transport or other hospital duties. Current robotic surgical platforms are single-purpose machines. A hospital could deploy one humanoid robot across multiple roles.
That versatility could matter most in rural and underserved regions, researchers said. Many such areas struggle to recruit surgical specialists. Teleoperated humanoid robots would let an experienced surgeon in a city hospital operate on a patient in a remote clinic without a full surgical team on site. The same technology could be used in disaster zones or temporary medical facilities where transporting a heavy conventional robot is impractical.
Still, the trial revealed clear limitations. The robots required repeated recalibration during the surgeries, making procedures significantly slower than existing robotic systems. Small delays between the surgeon's commands and the robot's movements remain a challenge, especially when the operator and robot are far apart. The operations were performed on large non-primate mammals. Human clinical trials will require extensive testing and regulatory approval before the technology reaches hospitals.
Researchers emphasized the technology is meant to assist surgeons, not replace them. Initial use would likely involve simpler tasks such as suturing or tissue retraction. More complex procedures could follow later, still under continuous human control.
The team plans to publish full results in a peer-reviewed journal later this year. A timeline for human trials has not been set.
For the surgical robotics market, the trial introduces a new variable. Humanoid robots could eventually compete with purpose-built platforms if the challenges of speed and precision are solved. That timeline is measured in years, researchers said, not quarters.
Drafted by a large language model from the source reporting linked above, then screened by automated publishing checks. It is not read by a journalist before publication. Some articles cite our Alpha Score. Verify prices and figures against the original source. Educational coverage, not personalized advice.